Paliperidone (ZINC04214700) is a second-generation antipsychotic agent, an active metabolite of risperidone, which is used for the treatment of schizophrenia by functioning as a dopamine D2 receptor antagonist and a serotonin 5-HT2 receptor antagonist [51,52,53]. The gene discussed is DRD2; the disease is schizophrenia.